Steve Schonfeld’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $374K | Buy |
+1,041
| New | +$318K | ﹤0.01% | 1945 |
|
|
2026
Q1 | – | Sell |
-3,513
| Closed | -$967K | – | 2733 |
|
|
2025
Q4 | $967K | Buy |
3,513
+2,741
| +355% | +$750K | ﹤0.01% | 1132 |
|
|
2025
Q3 | $203K | Sell |
772
-6,361
| -89% | -$1.55M | ﹤0.01% | 1944 |
|
|
2025
Q2 | $1.56M | Sell |
7,133
-6,564
| -48% | -$1.4M | 0.01% | 1104 |
|
|
2025
Q1 | $3.07M | Buy |
+13,697
| New | +$3.77M | 0.02% | 742 |
|
|
2024
Q1 | – | Sell |
-4,600
| Closed | -$1.62M | – | 2452 |
|
|
2023
Q4 | $1.62M | Buy |
+4,600
| New | +$1.63M | 0.01% | 870 |
|
|
2023
Q3 | – | Sell |
-5,914
| Closed | -$2.26M | – | 2356 |
|
|
2023
Q2 | $2.26M | Buy |
+5,914
| New | +$2.11M | 0.02% | 713 |
|
|
2023
Q1 | – | Sell |
-4,413
| Closed | -$1.04M | – | 2710 |
|
|
2022
Q4 | $1.04M | Sell |
4,413
-17,506
| -80% | -$4.15M | 0.01% | 1126 |
|
|
2022
Q3 | $5.39M | Buy |
+21,919
| New | +$6.68M | 0.05% | 507 |
|
|
2022
Q2 | – | Sell |
-2,462
| Closed | -$1.01M | – | 3053 |
|
|
2022
Q1 | $1.01M | Buy |
+2,462
| New | +$964K | 0.01% | 985 |
|
|
2021
Q2 | – | Sell |
-5,652
| Closed | -$1.59M | – | 2355 |
|
|
2021
Q1 | $1.59M | Buy |
5,652
+2,418
| +75% | +$692K | 0.02% | 730 |
|
|
2020
Q4 | $916K | Sell |
3,234
-1,407
| -30% | -$395K | 0.01% | 848 |
|
|
2020
Q3 | $1.28M | Buy |
+4,641
| New | +$1.23M | 0.02% | 640 |
|
|
2020
Q1 | – | Sell |
-3,150
| Closed | -$474K | – | 1573 |
|
|
2019
Q4 | $474K | Sell |
3,150
-4,773
| -60% | -$695K | 0.01% | 766 |
|
|
2019
Q3 | $1.12M | Buy |
+7,923
| New | +$1.09M | 0.03% | 446 |
|
|
2019
Q1 | – | Sell |
-10,444
| Closed | -$1.02M | – | 1320 |
|
|
2018
Q4 | $1.02M | Buy |
+10,444
| New | +$1.13M | 0.04% | 475 |
|
|
2018
Q2 | – | Sell |
-11,641
| Closed | -$1.03M | – | 1001 |
|
|
2018
Q1 | $1.03M | Buy |
+11,641
| New | +$1.09M | 0.08% | 318 |
|
|
2017
Q3 | – | Sell |
-3,107
| Closed | -$294K | – | 797 |
|
|
2017
Q2 | $294K | Buy |
+3,107
| New | +$286K | 0.03% | 483 |
|
|
2017
Q1 | – | Sell |
-9,079
| Closed | -$770K | – | 758 |
|
|
2016
Q4 | $770K | Sell |
9,079
-10,631
| -54% | -$836K | 0.1% | 265 |
|
|
2016
Q3 | $1.47M | Buy |
+19,710
| New | +$1.56M | 0.25% | 111 |
|
Other funds holding WST
Steve Schonfeld's WST Position: Q2 2026 in Review
Steve Schonfeld opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,041 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #1945 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in WST as recently as Q4 2025.
Steve Schonfeld first reported a position in WST in Q3 2016 and has held it in 20 quarters since. The position peaked at $5.39M in Q3 2022. 839 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Steve Schonfeld held 1,041 shares of West Pharmaceutical worth $374K as of Q2 2026.
- West Pharmaceutical was a new Steve Schonfeld position in Q2 2026.
- West Pharmaceutical made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1945 holding.
- Steve Schonfeld first reported a position in West Pharmaceutical in Q3 2016 and has held it in 20 quarters since.
- Steve Schonfeld's West Pharmaceutical position peaked at $5.39M in Q3 2022.
- 839 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.